AIG
ALLO icon

American International Group’s Allogene Therapeutics ALLO Stock Holding History

American International Group’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-46,567
Closed -$208K – 115
2024
Q1 		$208K Sell
46,567
-400
-0.9% -$1.67K ﹤0.01% 2123
2023
Q4 		$151K Buy
46,967
+5,955
+15% +$16.9K ﹤0.01% 2324
2023
Q3 		$130K Buy
41,012
+1,459
+4% +$6.39K ﹤0.01% 2364
2023
Q2 		$197K Buy
39,553
+1,090
+3% +$5.89K ﹤0.01% 2177
2023
Q1 		$190K Buy
38,463
+765
+2% +$4.91K ﹤0.01% 2138
2022
Q4 		$237K Sell
37,698
-137
-0.4% -$1.27K ﹤0.01% 2043
2022
Q3 		$409K Buy
37,835
+534
+1% +$7.26K ﹤0.01% 1699
2022
Q2 		$425K Buy
37,301
+3,540
+10% +$31.4K ﹤0.01% 1714
2022
Q1 		$308K Sell
33,761
-2,376
-7% -$24.7K ﹤0.01% 1990
2021
Q4 		$539K Sell
36,137
-1,081
-3% -$19.1K ﹤0.01% 1756
2021
Q3 		$957K Sell
37,218
-885
-2% -$21K 0.01% 1463
2021
Q2 		$994 Buy
38,103
+6,680
+21% +$190K ﹤0.01% 1513
2021
Q1 		$1.11K Buy
31,423
+83
+0.3% +$2.8K ﹤0.01% 1404
2020
Q4 		$791 Sell
31,340
-900
-3% -$29.3K ﹤0.01% 1518
2020
Q3 		$1.22M Buy
32,240
+2,572
+9% +$97K 0.01% 1155
2020
Q2 		$1.27M Buy
29,668
+6,706
+29% +$243K 0.01% 1113
2020
Q1 		$446K Sell
22,962
-1,326
-5% -$31.6K ﹤0.01% 1489
2019
Q4 		$631K Sell
24,288
-205
-0.8% -$5.65K ﹤0.01% 1565
2019
Q3 		$668K Sell
24,493
-171
-0.7% -$4.87K ﹤0.01% 1509
2019
Q2 		$662K Buy
24,664
+10,617
+76% +$296K ﹤0.01% 1543
2019
Q1 		$406K Sell
14,047
-31
-0.2% -$899 ﹤0.01% 1835
2018
Q4 		$379K Buy
+14,078
New +$374K ﹤0.01% 1825

Other funds holding ALLO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

American International Group's ALLO Position: Q2 2024 in Review

American International Group sold out of Allogene Therapeutics (ALLO) in Q2 2024, closing a stake of 46,567 shares — an estimated $208K sold.

American International Group first reported a position in ALLO in Q4 2018 and held it in 22 quarters. The position peaked at $1.27M in Q2 2020. 174 funds tracked by Wall St. Rank hold ALLO as of Q2 2024.

  • American International Group reported no remaining Allogene Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 46,567 Allogene Therapeutics shares in Q2 2024, an estimated $208K.
  • American International Group first reported a position in Allogene Therapeutics in Q4 2018 and held it in 22 quarters.
  • American International Group's Allogene Therapeutics position peaked at $1.27M in Q2 2020.
  • 174 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.